The European Hematology Congress brings together 11,000 physicians and researchers

IFEMA hosted from June 22 to 25 the second largest hematology congress in the world, for the first time in Madrid, organized by the European Hematology Association. Each subspecialty of this discipline was addressed during four days of education and connections, with a program that highlighted the latest findings in research as well as advances in the pharmaceutical field. It also offered peripheral programs and an exhibition area with pharmaceutical companies.

EULAR comes back

One of the largest congresses in the world returns to IFEMA: after its successful celebration at IFEMA in 2013, the EULAR (European League Against Rheumatism) congress returned with 15,000 delegates, from 14th to 17th of June.

The program addressed a wide range of issues and promoted interaction between physicians, scientists, people with arthritis / rheumatism, and the pharmaceutical industry. The results of the new initiatives of the EULAR School, the EULAR Campaign and the “RheumaMap”, a roadmap for research, were also presented. The congress also hosted EMEUNET EULAR, which brought together young rheumatologists.

IFEMA, a global player

Clemente González Soler, Chairman of the IFEMA Executive Committee, presented at the Forum of New Economy Forum, presented by Bankia President José Ignacio Goirigolzarri, the institution’s achievements of the last financial year and the strategic lines that will make it a global operator. “To be relevant in the international environment, we must grow. Therefore, the objective of the five-year plan is an average annual increase of 12%, to double our revenues and reach a turnover of 200 million euros in 2022”, 20% of which will come from international businesses. In fact, this issue of IFEMA News highlights several international initiatives.

González Soler recalled the excellent 2017 that IFEMA lives both in fairs and in congresses, with 12 large congresses”that will attract more than 120,000 congressmen to Madrid”. Also 2018 will be a good year, with the return of CPHI, the great fair of pharmaceutical ingredients (43,000 professionals). In addition, the institution has objectives of activities diversification, including major concerts and musical and cultural events that will keep the venues active all year round.

And the main goal is innovation, where IFEMA wants to be a reference. Among the keys of this innovation are digitization, which will include the development of an integrated website for customers and suppliers; the digitization of its communication and its infrastructures, and the creation of a digital environment that reflects the experience of the fair.

As a last reflection, González Soler wants IFEMA to grow as an example of the Madrid brand and the Spain project, showing “competence and confidence in management, efficiency in the use of public resources, credibility of its projects and highest standards for the public administration”. Also, during the presentation, the Chairwoman of the IFEMA Executive Committee pointed out that the institution analyzing or closing the integration of new venues in its portfolio, for instance the Palacio Municipal de Congresos.

Objective: to grow 12% per annum, reaching 200 million euros income in 2022